Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Purpura Thrombopenic”

559 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 559 results

Testing effectiveness (Phase 2)Looking for participantsNCT07043946
What this trial is testing

A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia (ITP)ITPBiologics+2 more
Climb Bio, Inc. 24
Not applicableStudy completedNCT03820960
What this trial is testing

Risk Factors for Thrombosis in Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
University Hospital, Toulouse 10,039
Not applicableStudy completedNCT03469661
What this trial is testing

Differential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS)

Who this might be right for
Immune ThrombocytopeniaMyelodysplastic Syndromes
Fundacion CRIS de Investigación para Vencer el Cáncer 63
Not applicableStudy completedNCT07150286
What this trial is testing

Helicobacter Pylori Eradication Therapy for Immune Thrombocytopenia (ITP) Patients in Iraq

Who this might be right for
Immune Thrombocytopenic PurpuraHELICOBACTER PYLORI INFECTIONS
Al-Mustansiriyah University 100
Not applicableUnknownNCT03377439
What this trial is testing

The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP

Who this might be right for
Immune Thrombocytopenia
Shandong University 400
Testing effectiveness (Phase 2)Looking for participantsNCT07063199
What this trial is testing

Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 30
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Testing effectiveness (Phase 2)Looking for participantsNCT07095127
What this trial is testing

Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)
Nuvig Therapeutics, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT00162006
What this trial is testing

Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura

Who this might be right for
Immune Thrombocytopenic Purpura (ITP)
Baxalta now part of Shire 28
Large-scale testing (Phase 3)Study completedNCT00362349
What this trial is testing

Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients

Who this might be right for
Idiopathic Thrombocytopenic Purpura (ITP)
CSL Limited 19
Very early researchLooking for participantsNCT07441525
What this trial is testing

UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases

Who this might be right for
Autoimmune Hemolytic AnemiaPrimary Immune Thrombocytopenic PurpuraEvans Syndrome
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 27
Large-scale testing (Phase 3)UnknownNCT01805648
What this trial is testing

Efficacy and Safety Study of Maintenance Treatment With rhTPO in Thrombocytopenic Subjects With ITP

Who this might be right for
ThrombocytopeniaImmune ThrombocytopeniaIdiopathic Thrombocytopenic Purpura
Peking Union Medical College 120
Testing effectiveness (Phase 2)Looking for participantsNCT06658834
What this trial is testing

Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP

Who this might be right for
Primary Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 129
Testing effectiveness (Phase 2)Looking for participantsNCT07362199
What this trial is testing

Anti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 20
Large-scale testing (Phase 3)Study completedNCT04132050
What this trial is testing

A Clinical Study in Patients With Chronic Idiopathic Thrombocytopenic Purpura in R788

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Kissei Pharmaceutical Co., Ltd. 34
Not applicableLooking for participantsNCT04014413
What this trial is testing

Safety and Efficacy of Fecal Microbiota Transplantation

Who this might be right for
Crohn DiseaseUlcerative ColitisCeliac Disease+24 more
Chinese University of Hong Kong 450
Large-scale testing (Phase 3)Study completedNCT02553317
What this trial is testing

Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura

Who this might be right for
Acquired Thrombotic Thrombocytopenic Purpura
Ablynx, a Sanofi company 145
Large-scale testing (Phase 3)Study completedNCT00511147
What this trial is testing

IGIV Study for Chronic ITP Patients Ages 3-70

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Grifols Biologicals, LLC 64
Testing effectiveness (Phase 2)Looking for participantsNCT06094881
What this trial is testing

A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05757570
What this trial is testing

An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias

Who this might be right for
Immune ThrombocytopeniaIdiopathic Thrombocytopenic PurpuraWarm Autoimmune Hemolytic Anemia+1 more
Alpine Immune Sciences, Inc. 30
Load More Results